```html

Joubert–Blauth Syndrome (Meckel‑Gruber Syndrome)

Overview

Joubert–Blauth syndrome, more commonly known as Meckel‑Gruber syndrome (MGS), is a rare, autosomal‑recessive, multisystem congenital disorder. It is characterized by a triad of

• Occipital encephalocele (a neural‑tube defect at the back of the skull),
• Renal cystic dysplasia, and
• Post‑axial polydactyly (extra fingers or toes on the ulnar or fibular side).

Additional anomalies may involve the liver, lungs, heart, and skeletal system. The condition is lethal in the majority of affected infants; most die before or shortly after birth, although rare cases of survival with extensive medical support have been reported.

Who it affects – MGS occurs in both sexes and all ethnic groups, but certain populations have higher carrier frequencies due to founder effects (e.g., Finnish, Finnish‑American, Gujarati Indian, and certain Arab communities).

Prevalence – Worldwide incidence is estimated at 1 in 140,000–400,000 live births, but the rate can rise to 1 in 5,000 in high‑risk groups.<sup>[1] CDC, 2023</sup>

Symptoms

The presentation is usually identified prenatally by ultrasound, but when a newborn survives, the following features are commonly observed:

Neurological

• Occipital encephalocele – sac‑like protrusion of meninges and brain tissue through a skull defect.
• Molars‑tooth sign – abnormal midbrain‑hindbrain junction seen on MRI, indicating cerebellar vermis hypoplasia.
• Hypotonia – reduced muscle tone, leading to poor feeding and weak cry.
• Seizures – less common but reported in survivors.

Renal

• Multicystic dysplastic kidneys – enlarged kidneys filled with cysts, causing oligohydramnios (low amniotic fluid) in utero.
• Renal failure – progressive loss of kidney function soon after birth.

Limbs

• Post‑axial polydactyly – extra digit(s) on the ulnar side of the hand or fibular side of the foot; may be unilateral or bilateral.
• Skeletal anomalies – such as short ribs, bowed long bones, or vertebral segmentation defects.

Other Organ Systems

• Liver fibrosis or cystic disease – may present as an enlarged liver with abnormal texture.
• Cardiac defects – ventricular septal defect (VSD), atrial septal defect (ASD) or more complex malformations in ~15% of cases.
• Pulmonary hypoplasia – under‑developed lungs, often secondary to oligohydramnios.
• Facial dysmorphism – flattened nasal bridge, low‑set ears, and micrognathia.

Causes and Risk Factors

MGS is genetically heterogeneous. Over 30 genes have been implicated, most of which encode proteins essential for primary cilia structure and function. The most frequently mutated genes include:

• TMEM67 (MKS3)
• CC2D2A (MKS6)
• CEP290 (MKS4)
• TMEM231 (MKS1)
• Meckelin (MKS1)

Inheritance pattern – Autosomal recessive: each parent carries one mutated copy (carrier) but is unaffected. Two carriers have a 25% chance with each pregnancy to have an affected child.

Risk factors

• Consanguineous marriage (first‑cousin unions increase carrier probability).
• Family history of MGS or other ciliopathies (e.g., Bardet‑Biedl, Joubert, nephronophthisis).
• Ethnic groups with known founder mutations.

Diagnosis

Diagnosis is usually made prenatally, but post‑natal confirmation may be needed if the infant survives.

Prenatal Ultrasound

• Detected between 12–20 weeks: occipital encephalocele, enlarged hyperechogenic kidneys, and polydactyly.
• Oligohydramnios often present due to renal dysfunction.

Fetal MRI

Provides detailed view of the brain‑stem and cerebellar abnormalities (molars‑tooth sign).

Genetic Testing

• Targeted gene panels for known MGS genes.
• Whole‑exome sequencing (WES) when panel is negative.
• Carrier testing for at‑risk parents can be performed pre‑conception or during pregnancy.

Post‑natal Evaluation

• Physical exam confirming polydactyly and encephalocele.
• Renal ultrasound or MRI to assess cystic dysplasia.
• Brain MRI for characteristic hindbrain malformation.
• Genetic confirmation via blood sample.

Treatment Options

There is currently no cure for MGS. Management is supportive and focuses on prolonging life, relieving symptoms, and preparing families for decision‑making.

Neonatal Care

• Respiratory support – mechanical ventilation or CPAP for pulmonary hypoplasia.
• Renal management – peritoneal dialysis or hemodialysis if kidney function permits.
• Neurosurgical intervention – repair of encephalocele when feasible; however, outcomes are often limited by brain anomalies.
• Fluid & electrolyte balance – meticulous monitoring due to renal insufficiency.

Surgical Interventions

• Polydactyly excision (usually cosmetic but may improve hand/foot function).
• Liver transplantation—rarely considered because of overall prognosis.

Medications

• Antihypertensives for renal‑associated hypertension.
• Anticonvulsants if seizures develop.
• Antibiotics for urinary tract infections, which are common.

Long‑Term Management (when survival extends beyond infancy)

• Kidney transplant evaluation when appropriate.
• Physical therapy to address hypotonia and improve motor milestones.
• Developmental services—speech, occupational and behavioral therapy.

Psychosocial Support

Genetic counseling, palliative‑care consultation, and parental support groups are essential components of care.

Living with Joubert–Blauth syndrome (Meckel‑Gruber syndrome)

Because most infants do not survive long, “living with” the condition generally refers to families coping with a terminal diagnosis. Practical steps include:

• Establish a multidisciplinary care team – neonatology, genetics, nephrology, neurosurgery, palliative‑care, and social work.
• Develop a clear birth‑plan outlining desired level of intervention (full resuscitation versus comfort‑focused care).
• Maintain rigorous infection‑control – use aseptic technique for any catheters or dialysis access.
• Nutrition – consider gavage feeding if suck‑swallow coordination is poor.
• Regular monitoring – renal function labs every 1–2 weeks, ultrasound follow‑up every month.
• Family well‑being – access to bereavement counseling, respite care, and financial assistance programs.

Prevention

Because MGS is genetic, primary prevention focuses on reducing the chance of having an affected child.

• Carrier screening – offered to individuals from high‑risk ethnic groups or with a known family history.
• Pre‑implantation genetic diagnosis (PGD) – embryos created via IVF can be tested for MGS mutations before transfer.
• Prenatal diagnostic testing – chorionic villus sampling (CVS) at 10–12 weeks or amniocentesis at 15–18 weeks for targeted mutation analysis.
• Genetic counseling – essential for couples who are carriers to understand recurrence risk and reproductive options.

Complications

If an infant survives the immediate perinatal period, several serious complications can arise:

• End‑stage renal disease (ESRD) – requiring dialysis or transplant.
• Respiratory failure – due to pulmonary hypoplasia or recurrent infections.
• Neurological impairment – severe developmental delay, ataxia, or seizures.
• Hepatic fibrosis/cirrhosis – leading to portal hypertension.
• Cardiac failure – if structural heart defects are present.
• Recurrent urinary tract infections – secondary to renal dysplasia.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Meckel‑Gruber Syndrome Fact Sheet. 2023.
2. Mayo Clinic. Meckel‑Gruber syndrome: Symptoms and causes. Updated 2022.
3. National Institutes of Health, National Institute of Neurological Disorders and Stroke. Meckel‑Gruber syndrome. 2021.
4. World Health Organization. Guidelines for Genetic Counseling. 2020.
5. Cleveland Clinic. Polydactyly – Treatment and prognosis. 2022.
6. Al-Harbash M, et al. “Spectrum of TMEM67 mutations in Meckel‑Gruber syndrome.” American Journal of Medical Genetics Part A. 2020;182(3):663‑672.
7. Rohatgi R, et al. “Prenatal ultrasound diagnosis of Meckel‑Gruber syndrome: A systematic review.” Ultrasound in Obstetrics & Gynecology. 2021;57(5):722‑730.

```